Dr. Claudia Padilla discusses Alzheimer’s and a new treatment.

Claudia Padilla, MD, at Baylor Scott & White Health, discusses Alzheimer’s and a new treatment. What You Need to Know: Alzheimer’s disease is a type of dementia. The most common sign is short-term memory loss. New medication targets the protein…

Cerebral amyloid angiopathy, seizures, and epilepsy: Dr. Brin Freund

Sixty percent of patients with dementia on autopsy studies have cerebral amyloid angiopathy (CAA) pathology. This episode discusses the relationship between CAA and epilepsy through the lens of a recent publication. Dr. Alina Ivaniuk talks with Dr. Brin Freund.

Eartest by Eartone Application Detects Dementia Risk by Checking the Hearing of Words in Thai language

The Faculties of Medicine and Science, Chulalongkorn University, in collaboration with University College London (UCL), the United Kingdom, together with industrial partner have developed Eartest by Eartone Application that examines hearing with Thai words processing that the public can use to screen dementia by themselves before consulting physicians to help prevent and reduce future risk of dementia.

Chula Medicine Reveals Innovative Detection of Latent Dementia A 10-Year Awareness May delay Alzheimer’s Onset in Elderly

Thai Red Cross Emerging Infectious Diseases Health Science Center, Faculty of Medicine, Chulalongkorn University has researched a blood test for markers of Alzheimer’s that can give a 10-year warning, so people can be prepared to slow down the development of dementia in old age.

A Pré-eclâmpsia está associada a indicadores de maior risco de danos e inflamação nas células cerebrais

Pesquisadores da Mayo Clinic descobriram que mulheres com histórico de pré-eclâmpsia grave têm mais indicadores de maior risco de danos e inflamação das células cerebrais em comparação com mulheres que tiveram gestações sem complicações.

Chula’s Innovations for the Aging Society

As one of the countries with a rapidly increasing aging population, especially this 2022, Thailand is now becoming an ‘aging’ society and will likely become a ‘super-aging society’ by 2031. To better meet the needs and provide services to the nation’s aging society, experts from various fields at Chulalongkorn University have conducted research to produce and develop innovations for the elderly.

Chula Dementia Day Center Can Help You Prepare for Old Age with a Clear Mind and Away from Alzheimer’s

Dementia Day Center, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society prepares for Thailand’s anticipated aging society by offering various rehabilitation services to help slow down the decline of people with dementia, while planning to launch a professional course for caregivers, and establishing the “Bright Brain Club” to persuade people of all ages to learn and care for early brain health to avoid the possibility Alzheimer’s disease.

Muscle Protein That Makes Vertebrates More Fit Linked to Limited Lifespan

Researchers from Johns Hopkins Medicine say they have added to evidence that a protein called CaMKII improves strength, endurance, muscle health and fitness in young animals. Their experiments working with mice and fruit flies, however, found that the gene for CaMKII also contributes to an evolutionary tradeoff: increased susceptibility to age-associated diseases, frailty and mortality.

University of Miami Miller School Plays Pivotal Role in Securing a $15 Million National Alzheimer’s Disease Research Center

University of Miami Miller School of Medicine investigators play a pivotal role in a consortium of Florida institutions just awarded a $15 million grant to collaborate on Alzheimer’s disease research. The five-year National Institutes of Health/National Institute on Aging grant brings together top Florida researchers to focus on better understanding how to diagnose, treat, prevent, and potentially cure Alzheimer’s in diverse populations.

Blood Vessel Defects in Eyes May Foretell Alzheimer’s

Alzheimer’s disease in its early stages affects the integrity of small blood vessels in the retinas of patients, according to a recent study led by Cedars-Sinai. This discovery holds promise for early diagnosis of Alzheimer’s through the retina, a back-of-the-eye organ that is an extension of the brain and easily accessible for live, noninvasive imaging.

Embargoed: Forthcoming Report To Examine Alzheimer’s and Other Dementias in U.S.

The Alzheimer’s Association will issue the 2020 Alzheimer’s Diseases Facts and Figures Report on March 11, 2020. The new report will highlight the latest disease-related statistics for America’s 6th leading cause of death for those 65+, including prevalence, incidence, mortality, costs of care and impact on caregivers both nationally, as well as state by state data, for both 2020 and future projections. This new report will feature findings from a first-of-its-kind, comprehensive survey of primary care physicians (PCPs) and medical school residents which examines the medical profession’s readiness to meet future care needs for the growing number of people living with Alzheimer’s and other dementias. Information and report findings are under strict embargo until Wednesday, March 11, 2020.

IU School of Medicine awarded $36 million NIH grant for Alzheimer’s disease drug discovery center

The IU-led center is one of only two multi-institution teams in the nation selected as part of a new federal program intended to improve, diversify and reinvigorate the Alzheimer’s disease drug development pipeline.